General

Complementary/Alternative Medicine: This monograph describes a natural or herbal product that is not subject to FDA guidelines for medicines. Patients and clinicians are advised to read package labels carefully to ensure safe and efficacious use.

Pronunciation:
les-uh-thin


Trade Name(s)

  • egg lecithin
  • soy lecithin

Ther. Class.
lipid-lowering agents
anti-Alzheimers's agents
performance enhancers

Common Uses

  • Hepatic steatosis.
  • Alzheimer's dementia.
  • Hypercholesterolemia.
  • Tardive dyskinesia.
  • Mania.
  • Improving athletic performance.

Action

Lecithin is a phospholipid found in egg yolks, organ meats, nuts, and spinach. It contains phosphatidylcholine, which contains choline which is a precursor to acetylcholine. Lecithin also increases omega-6 fatty acid levels.

Therapeutic Effect(s):

  • Decreased cholesterol levels.
  • As a source of choline, lecithin may improve symptoms of cholinergic diseases.

Pharmacokinetics

Absorption: Unknown

Distribution: Unknown

Metabolism and Excretion: Unknown

Half-life: Unknown

TIME/ACTION PROFILE

ONSETPEAKDURATION
POunknownunknownunknown

Contraindication/Precautions

Contraindicated in:

  • Hypersensitivity.
  • Egg and soy allergy.

Use Cautiously in:

Pregnancy and lactation (when using amounts greater than found in foods).

Adverse Reactions/Side Effects

Derm: skin reactions (in soy and egg allergic patients)

GI: diarrhea, nausea, abdominal pain

* CAPITALS indicate life-threatening.
Underline indicate most frequent.

Interactions

Natural Drug Interaction

None.

Natural-Natural:

None.

Route/Dosage

PO: (Adults) Hypercholesterolemia –20–30 g/day. Athletic performance –3.6 g twice daily. Tardive dyskinesia– 20–50 g/day. Mania– 10 mg three times daily.Dementia– 1.2–45 g/day.

Availability

Capsules
Liquid
Granules

Assessment

  • Assess mental status and memory periodically during therapy.

Lab Test Considerations:

Monitor liver function tests prior to and periodically during therapy.

Potential Diagnoses

Implementation

  • PO: Administer 1 to 3 times daily.

Patient/Family Teaching

  • Instruct patient to take lecithin as directed.
  • Advise female patient to notify health care professional if pregnancy is planned or suspected or if breastfeeding.

Evaluation/Desired Outcomes

  • Decrease in serum cholesterol.
  • Improvement in signs and symptoms of cholinergic diseases.
lecithin is a sample topic from the Davis's Drug Guide.

To view other topics, please or purchase a subscription.

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Learn more.

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - lecithin ID - 109946 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/109946/all/lecithin PB - F.A. Davis Company ET - 16 DB - Anesthesia Central DP - Unbound Medicine ER -